{"title":"从感觉行为、大脑和表观遗传因素剖析自闭症谱系障碍的异质性。","authors":"Yongjeon Cheong, Jihyun Bae, Seonkyoung Lee, Jihyeong Ro, Hidehiko Okazawa, Hirotaka Kosaka, Minyoung Jung","doi":"10.1038/s41398-025-03566-2","DOIUrl":null,"url":null,"abstract":"<p><p>Autism spectrum disorder (ASD), a disorder with heterogeneous etiology, is characterized by abnormal behavioral responses to sensory inputs. However, there is still limited understanding of how brain and epigenetic factors, along with behavioral abnormality, contribute to ASD. After completing Adolescent-Adult Sensory Profile, a self-report questinnaire, 34 individuals with ASD and 72 controls underwent neuroimaging scans to measure brain structural (cortical and subcortical volume) and functional (thalamo-cortical resting-state functional connectivity) characteristics. For epigenetic measures, we computed DNA methylation values of the oxytocin receptor and arginine vasopressin receptor (AVPR) genes from the participants' saliva. When sensory-related behavior was the default baseline, a machine learning algorithm demonstrated that the neuroimaging-epigenetic model outperformed the neuroimaging model or the epigenetic model. Thalamo-cortical hyperconnectivity and AVPR 1A epigenetic modification were found to be significant contributing factors in these models. By integrating neuroimaging and epigenetic biomarkers with behaviors, a more precise diagnosis of ASD can be achieved.</p>","PeriodicalId":23278,"journal":{"name":"Translational Psychiatry","volume":"15 1","pages":"337"},"PeriodicalIF":6.2000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12402529/pdf/","citationCount":"0","resultStr":"{\"title\":\"Dissecting the heterogeneity of autism spectrum disorder with sensory behavior, brain, and epigenetic factors.\",\"authors\":\"Yongjeon Cheong, Jihyun Bae, Seonkyoung Lee, Jihyeong Ro, Hidehiko Okazawa, Hirotaka Kosaka, Minyoung Jung\",\"doi\":\"10.1038/s41398-025-03566-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Autism spectrum disorder (ASD), a disorder with heterogeneous etiology, is characterized by abnormal behavioral responses to sensory inputs. However, there is still limited understanding of how brain and epigenetic factors, along with behavioral abnormality, contribute to ASD. After completing Adolescent-Adult Sensory Profile, a self-report questinnaire, 34 individuals with ASD and 72 controls underwent neuroimaging scans to measure brain structural (cortical and subcortical volume) and functional (thalamo-cortical resting-state functional connectivity) characteristics. For epigenetic measures, we computed DNA methylation values of the oxytocin receptor and arginine vasopressin receptor (AVPR) genes from the participants' saliva. When sensory-related behavior was the default baseline, a machine learning algorithm demonstrated that the neuroimaging-epigenetic model outperformed the neuroimaging model or the epigenetic model. Thalamo-cortical hyperconnectivity and AVPR 1A epigenetic modification were found to be significant contributing factors in these models. By integrating neuroimaging and epigenetic biomarkers with behaviors, a more precise diagnosis of ASD can be achieved.</p>\",\"PeriodicalId\":23278,\"journal\":{\"name\":\"Translational Psychiatry\",\"volume\":\"15 1\",\"pages\":\"337\"},\"PeriodicalIF\":6.2000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12402529/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational Psychiatry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41398-025-03566-2\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41398-025-03566-2","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
Dissecting the heterogeneity of autism spectrum disorder with sensory behavior, brain, and epigenetic factors.
Autism spectrum disorder (ASD), a disorder with heterogeneous etiology, is characterized by abnormal behavioral responses to sensory inputs. However, there is still limited understanding of how brain and epigenetic factors, along with behavioral abnormality, contribute to ASD. After completing Adolescent-Adult Sensory Profile, a self-report questinnaire, 34 individuals with ASD and 72 controls underwent neuroimaging scans to measure brain structural (cortical and subcortical volume) and functional (thalamo-cortical resting-state functional connectivity) characteristics. For epigenetic measures, we computed DNA methylation values of the oxytocin receptor and arginine vasopressin receptor (AVPR) genes from the participants' saliva. When sensory-related behavior was the default baseline, a machine learning algorithm demonstrated that the neuroimaging-epigenetic model outperformed the neuroimaging model or the epigenetic model. Thalamo-cortical hyperconnectivity and AVPR 1A epigenetic modification were found to be significant contributing factors in these models. By integrating neuroimaging and epigenetic biomarkers with behaviors, a more precise diagnosis of ASD can be achieved.
期刊介绍:
Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod''s discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.